In our case, immunohistochemistry was crucial: CD20 and BCL6 confirmed the B-cell lineage, CD3 and CD68 highlighted the abundant T cells and histiocytes typical of the microenvironment, and the absence of CD30/CD15 effectively ruled out CHL. The gene discussed is TNFRSF8; the disease is classic Hodgkin lymphoma.